Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Jersey, United States,- Mr Accuracy Reports published new research on Global Computational Biology covering micro level of ana
Compugen (NASDAQ:CGEN – Get Rating) and ProKidney (NASDAQ:PROK – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings and recommmendations […]
The CTLA-4 inhibitors pipeline and clinical trial analysis report deliver important insights on ongoing research, clinical strategies, upcoming therapeutics, and commercial analysis. LAS
/PRNewswire/ -- DelveInsight's 'CTLA-4 Inhibitors Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...
StockNews.com assumed coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a research note published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the company. Jefferies Financial Group cut Compugen from a hold rating to an underperform […]